Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Ashitaba (Angelica keiskei) has been traditionally used in Japan as a health-promoting herb, and recent scientific interest has explored its potential anti-diabetic effects. Preclinical studies have identified several bioactive compounds in ashitaba, notably chalcones such as 4-hydroxyderricin and xanthoangelol, which may influence glucose metabolism. Animal studies suggest that ashitaba extracts can help lower blood glucose levels, improve insulin sensitivity, and reduce oxidative stress associated with diabetes. For example, research published in Journal of Natural Medicines (2015) demonstrated that ashitaba chalcones improved insulin resistance in obese mice. In vitro experiments have also found that ashitaba compounds can inhibit alpha-glucosidase, an enzyme involved in carbohydrate digestion, thereby slowing glucose absorption.

However, there is a lack of robust clinical trials in humans directly supporting ashitaba’s efficacy for diabetes management. Most evidence comes from laboratory and animal studies, and human data are limited to anecdotal reports or indirect findings. Thus, while scientific investigation is ongoing and some promising mechanisms have been identified, the current level of evidence for ashitaba’s use in diabetes is preliminary. Individuals considering ashitaba for diabetes should do so with caution and consult healthcare professionals, as more research is needed to confirm its safety and effectiveness in humans.

More about ashitaba
More about Diabetes

Other ingredients used for Diabetes

Other health conditions supported by ashitaba

Products containing ashitaba

Vitabase Life's Essentials Plus